2015 Spring ADRC Meeting presentations
For an individual presentation, click the presentation title.
Administrators Meeting
- Administrators Meeting
- Public/private partnerships in research: Perspectives from the Foundation for the National Institutes of Health
- Rosa Canet-Aviles, PhD; Scientific Program Manager, Neuroscience, FNIH
- Initial development and research applications of PET tau imaging with 18F-AV-1451 (aka 18F-T807)
- Mark A. Mintun, MD; Chief Medical Officer, Avid Radiopharmaceuticals
- Continuous in-home assessment: New approaches to assessing health
- Jeffrey Kaye, MD; Director, Oregon Health & Science University
- The not-so-grim RPPR
- Cerise Elliott, PhD; Research Program Analyst, Division of Neuroscience, NIA/NIH
- Krista Moulder, PhD (panel chair); Associate Administrator, Washington University in St. Louis
- Mary Sundsmo, MBA; Administrator, University of California, San Diego
- Sleep disorders most pertinent to dementia research: RBD and OSA
- Bradley Boeve, MD; Clinical Core Co-Leader, Mayo Clinic
Panel: How do we get it all done? By "standing on the shoulders" of …
- Panel: How do we get it all done? By "standing on the shoulders" of …
- Senior volunteers in the community
- Anne Arthur, APRN, BC; Administrator, University of Kansas
- Undergraduate summer interns
- Amanda Burden, BA (panel chair); Administrator, Mount Sinai
- Apps and technology
- Maggie Dean, BS; Research Manager, National Alzheimer's Coordinating Center
- The people all around you
- Bradley Glazier; Administrator, Indiana University
Directors Meeting
- Directors Meeting
- NIA update
- Richard Hodes, MD; Director, NIA
- NACC and UDS3 update
- Walter A. Kukull, PhD; Director, National Alzheimer's Coordinating Center
- ADGC update
- Gerard Schellenberg, PhD; P.I., Alzheimer's Disease Genetics Consortium
- NIAGADS update
- Gerard Schellenberg, PhD (for Li-San Wang, PhD; P.I., NIAGADS)
- NCRAD update
- Tatiana Foroud, PhD; P.I., National Cell Repository for Alzheimer's Disease
Scientific symposium: Discovery of therapeutics
- Alzheimer's Prevention Initiative
- Eric Reiman, MD; Director, Arizona ADRC
- Intranasal insulin and Alzheimer’s disease: Diversifying the AD therapeutic portfolio
- Suzanne Craft, PhD; Project 2 Leader, University of Washington
- Targeting the p75 receptor to inhibit AD degenerative signaling and tau phosphorylation/ misfolding/ missorting: preclinical through phase 1
- Frank Longo, MD; Director, Stanford University
- Small-molecule modulation of CD33
- Elizabeth Bradshaw, PhD; Brigham and Women's Hospital
Clinical Core Leaders Meeting
- Clinical Core Leaders Meeting presentations
- What should we do until we have a prevention for AD? Practices and investigational approaches to symptom management
- Steven E. Arnold, MD; Chair, Clinical Core Leaders Steering Committee
- Pharmacological approaches for cognition
- Martin R. Farlow, MD; Clinical Core Leader, Indiana University
- Physical exercise and non-pharamacological approaches for cognition
- Laura D. Baker, PhD; Associate Professor, Wake Forest University
- Maximizing independence (MIND) at home and community-based dementia care coordination
- Constantine Lyketsos, MD; Clinical Core Leader, Johns Hopkins University
- Prazosin for agitation management in dementia
- Murray A. Raskind, MD; ORE Core Leader, University of Washington